C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 11,016 | 11,230 | 6,463 | 7,238 | 5,177 |
| Gross Profit | 11,016 | 11,230 | 6,463 | 7,238 | 5,177 |
| Operating Expenses | 34,161 | 45,642 | 34,964 | 36,402 | 42,886 |
| Operating Income | -23,145 | -34,412 | -28,501 | -29,164 | -37,709 |
| Interest Expense | -5,026 | 0 | -2,481 | -2,842 | -6,845 |
| Other Income | -2,246 | 2,246 | 0 | 0 | -3,578 |
| Pre-tax Income | -20,365 | -32,166 | -26,020 | -26,322 | -34,442 |
| Net Income Continuous | -20,486 | -32,166 | -26,020 | -26,322 | -34,573 |
| Net Income | $-20,486 | $-32,166 | $-26,020 | $-26,322 | $-34,573 |
| EPS Basic Total Ops | -0.09 | -0.44 | -0.37 | -0.37 | -0.50 |
| EPS Basic Continuous Ops | -0.09 | -0.44 | -0.37 | -0.37 | -0.49 |
| EPS Diluted Total Ops | -0.09 | -0.44 | -0.37 | -0.37 | -0.50 |
| EPS Diluted Continuous Ops | -0.09 | -0.44 | -0.37 | -0.37 | -0.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.44 | -0.37 | -0.37 | -0.49 |
| EBITDA(a) | $-23,580 | $-34,467 | $-28,467 | $-29,491 | $-38,310 |